{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:52:02Z","timestamp":1782143522824,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.biopha.2018.10.191","type":"journal-article","created":{"date-parts":[[2018,11,4]],"date-time":"2018-11-04T00:02:52Z","timestamp":1541289772000},"page":"639-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis"],"prefix":"10.1016","volume":"109","author":[{"given":"Francielle","family":"Graus-Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2510-9569","authenticated-orcid":false,"given":"Vanessa","family":"Souza-Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.10.191_bib0005","series-title":"Human Physiology","author":"Petersen","year":"2007"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.10.191_bib0010","first-page":"34S","article-title":"New insights into the pathogenesis of insulin resistance in humans using magnetic resonance spectroscopy","volume":"14","author":"Petersen","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.191_bib0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbrc.2015.03.153","article-title":"Islet beta-cell failure in type 2 diabetes\u2013within the network of toxic lipids","volume":"460","author":"Janikiewicz","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.191_bib0020","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.2000.278.1.E1","article-title":"The adipoinsular axis: effects of leptin on pancreatic beta-cells","volume":"278","author":"Kieffer","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.191_bib0025","first-page":"RA12","article-title":"High fat diet modulation of glucose sensing in the beta-cell","volume":"13","author":"Cerf","year":"2007","journal-title":"Med. Sci. Monit."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.10.191_bib0030","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0168-8227(11)70012-2","article-title":"Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy?","volume":"93","author":"van Raalte","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2018.10.191_bib0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2016.10.021","article-title":"Differential effects of angiotensin receptor blockers on pancreatic islet remodelling and glucose homeostasis in diet-induced obese mice","volume":"439","author":"Graus-Nunes","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00125-003-1295-1","article-title":"Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets","volume":"47","author":"Lau","year":"2004","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.biopha.2018.10.191_bib0045","doi-asserted-by":"crossref","first-page":"E435","DOI":"10.1152\/ajpendo.00391.2014","article-title":"Modulation of glucose metabolism by the renin-angiotensin-aldosterone system","volume":"308","author":"Favre","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.191_bib0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1463-1326.2012.01559.x","article-title":"Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms","volume":"14","author":"van der Zijl","year":"2012","journal-title":"Diabetes Obes. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.191_bib0055","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S1357-2725(02)00179-6","article-title":"A local pancreatic renin-angiotensin system: endocrine and exocrine roles","volume":"35","author":"Leung","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0060","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-12-0341","article-title":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system","volume":"216","author":"Santos","year":"2013","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.191_bib0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1677\/joe.0.1790081","article-title":"Angiotensinogen localization and secretion in the rat pancreas","volume":"179","author":"Regoli","year":"2003","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1677\/joe.0.1610317","article-title":"The tissue renin-angiotensin system in human pancreas","volume":"161","author":"Tahmasebi","year":"1999","journal-title":"J. Endocrinol."},{"issue":"2A","key":"10.1016\/j.biopha.2018.10.191_bib0075","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/S0002-9149(01)02321-9","article-title":"The role of the renin-angiotensin system in the development of cardiovascular disease","volume":"89","author":"Unger","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.191_bib0080","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/diabetes.53.4.989","article-title":"Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat","volume":"53","author":"Tikellis","year":"2004","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.biopha.2018.10.191_bib0085","doi-asserted-by":"crossref","first-page":"R1223","DOI":"10.1152\/ajpregu.00362.2016","article-title":"High-fat diet-induced glucose dysregulation is independent of changes in islet ACE2 in mice","volume":"311","author":"Chodavarapu","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.191_bib0090","article-title":"The ACE2\/ANG(1-7)\/Mas axis regulates the development of pancreatic endocrine cells in mouse embryos","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"Pt 1","key":"10.1016\/j.biopha.2018.10.191_bib0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1113\/jphysiol.2006.126193","article-title":"The physiology of a local renin-angiotensin system in the pancreas","volume":"580","author":"Leung","year":"2007","journal-title":"J. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.191_bib0100","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jdi.12094","article-title":"Glucose-stimulated insulin secretion: a newer perspective","volume":"4","author":"Komatsu","year":"2013","journal-title":"J. Diabetes Investig."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.191_bib0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/nyas.13448","article-title":"Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes","volume":"1411","author":"Lu","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cmet.2013.05.018","article-title":"Metabolic signaling in fuel-induced insulin secretion","volume":"18","author":"Prentki","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2018.10.191_bib0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-90-481-3271-3_5","article-title":"High fat programming of beta-cell failure","volume":"654","author":"Cerf","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11 Pt 2","key":"10.1016\/j.biopha.2018.10.191_bib0120","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1016\/j.amjhyper.2004.08.004","article-title":"The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications","volume":"17","author":"Cooper","year":"2004","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/eje.1.02086","article-title":"The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets","volume":"154","author":"Lupi","year":"2006","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbadis.2009.10.009","article-title":"Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice","volume":"1802","author":"Kikumoto","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mce.2008.09.020","article-title":"The sweeter side of ACE2: physiological evidence for a role in diabetes","volume":"302","author":"Bindom","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"12","key":"10.1016\/j.biopha.2018.10.191_bib0140","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1210\/en.2016-1247","article-title":"The angiotensin-(1-7)\/Mas axis improves pancreatic beta-cell function in vitro and in vivo","volume":"157","author":"Sahr","year":"2016","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.191_bib0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3164\/jcbn.09-83","article-title":"A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL\/6 mice fed a high fat diet","volume":"46","author":"Fraulob","year":"2010","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.191_bib0150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/obr.12246","article-title":"Metabolic vs. Hedonic obesity: a conceptual distinction and its clinical implications","volume":"16","author":"Yu","year":"2015","journal-title":"Obes. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.191_bib0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tem.2015.01.006","article-title":"Insulin resistance and impaired adipogenesis","volume":"26","author":"Gustafson","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.biopha.2018.10.191_bib0160","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/en.2010-0102","article-title":"Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic beta-cell leptin signaling","volume":"151","author":"Gray","year":"2010","journal-title":"Endocrinology"},{"issue":"Suppl. 2","key":"10.1016\/j.biopha.2018.10.191_bib0165","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2337\/dc09-S301","article-title":"Defining and characterizing the progression of type 2 diabetes","volume":"32","author":"Fonseca","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.biopha.2018.10.191_bib0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/JPEM.2003.16.1.5","article-title":"Glucotoxicity and beta-cell failure in type 2 diabetes mellitus","volume":"16","author":"Kaiser","year":"2003","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.191_bib0175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPA.0b013e3182153922","article-title":"Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL\/6 mice","volume":"40","author":"Souza-Mello","year":"2011","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.191_bib0180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrgastro.2011.4","article-title":"The clinical significance of pancreatic steatosis","volume":"8","author":"Smits","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0185","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ijo.2009.245","article-title":"Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents","volume":"34","author":"Lee","year":"2010","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"11","key":"10.1016\/j.biopha.2018.10.191_bib0190","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1210\/en.2008-0070","article-title":"Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat","volume":"149","author":"Habibi","year":"2008","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0195","doi-asserted-by":"crossref","first-page":"C313","DOI":"10.1152\/ajpcell.00575.2008","article-title":"Angiotensin II exerts glucose-dependent effects on Kv currents in mouse pancreatic beta-cells via angiotensin II type 2 receptors","volume":"298","author":"Chu","year":"2010","journal-title":"Am. J. Physiol., Cell Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/03009734.2016.1164769","article-title":"Pancreatic islet blood flow and its measurement","volume":"121","author":"Jansson","year":"2016","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.biopha.2018.10.191_bib0205","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/405284","article-title":"Angiotensin-converting enzyme 2 deficiency aggravates glucose intolerance via impairment of islet microvascular density in mice with high-fat diet","volume":"2013","author":"Yuan","year":"2013","journal-title":"J. Diabetes Res."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.191_bib0210","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.2337\/db06-0690","article-title":"Pancreatic islet production of vascular endothelial growth factor\u2013a is essential for islet vascularization, revascularization, and function","volume":"55","author":"Brissova","year":"2006","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.biopha.2018.10.191_bib0215","doi-asserted-by":"crossref","first-page":"E621","DOI":"10.1152\/ajpendo.00054.2015","article-title":"ACE2 deficiency reduces beta-cell mass and impairs beta-cell proliferation in obese C57BL\/6 mice","volume":"309","author":"Shoemaker","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/micc.12094","article-title":"Angiotensin II regulates islet microcirculation and insulin secretion in mice","volume":"21","author":"Ihoriya","year":"2014","journal-title":"Microcirculation"},{"issue":"8","key":"10.1016\/j.biopha.2018.10.191_bib0225","doi-asserted-by":"crossref","first-page":"E874","DOI":"10.1152\/ajpendo.00490.2012","article-title":"Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice","volume":"304","author":"Chhabra","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9545","key":"10.1016\/j.biopha.2018.10.191_bib0230","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(06)69442-7","article-title":"Oral renin inhibitors","volume":"368","author":"Staessen","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2018.10.191_bib0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00125-009-1575-5","article-title":"Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes","volume":"53","author":"Dong","year":"2010","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.biopha.2018.10.191_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067192","article-title":"Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice","volume":"8","author":"Frantz","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.191_bib0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030563","article-title":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse","volume":"18","author":"Roca-Ho","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.biopha.2018.10.191_bib0250","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1097\/QAD.0000000000001587","article-title":"Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients","volume":"31","author":"Lemoine","year":"2017","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.biopha.2018.10.191_bib0255","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2337\/db14-1282","article-title":"Angiotensin II induces interleukin-1beta-mediated islet inflammation and beta-cell dysfunction independently of vasoconstrictive effects","volume":"64","author":"Sauter","year":"2015","journal-title":"Diabetes"},{"issue":"16","key":"10.1016\/j.biopha.2018.10.191_bib0260","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12900","article-title":"Oxidative stress increases the risk of pancreatic beta cell damage in chronic renal hypertensive rats","volume":"4","author":"Gao","year":"2016","journal-title":"Physiol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.191_bib0265","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbrc.2017.11.055","article-title":"Angiotensin-converting enzyme 2 regulates mitochondrial function in pancreatic beta-cells","volume":"495","author":"Shi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.biopha.2018.10.191_bib0270","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s10620-018-5036-1","article-title":"Anti-inflammatory and antioxidant effects of captopril compared to methylprednisolone in L-arginine-Induced acute pancreatitis","volume":"63","author":"El-Ashmawy","year":"2018","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0275","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/15384047.2014.1002357","article-title":"Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice","volume":"16","author":"Ishiguro","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.191_bib0280","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/dvdy.24084","article-title":"Angiotensin II type 2 receptor regulates the development of pancreatic endocrine cells in mouse embryos","volume":"243","author":"Leung","year":"2014","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.biopha.2018.10.191_bib0285","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/319586","article-title":"Improved glucose-stimulated insulin secretion by selective intraislet inhibition of angiotensin ii type 1 receptor expression in isolated islets of db\/db mice","volume":"2013","author":"Zhang","year":"2013","journal-title":"Int. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.191_bib0290","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00210-017-1346-7","article-title":"Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic alpha-cell-dependent mechanism","volume":"390","author":"Mildner","year":"2017","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.191_bib0295","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/ars.2007.1590","article-title":"Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice","volume":"9","author":"Chu","year":"2007","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.191_bib0300","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.109.148049","article-title":"Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice","volume":"55","author":"Cole","year":"2010","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0305","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/diabetes.55.02.06.db05-1022","article-title":"Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes","volume":"55","author":"Chu","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.biopha.2018.10.191_bib0310","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mce.2010.08.019","article-title":"Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets","volume":"331","author":"Toffoli","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.191_bib0315","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3892\/ijmm.2014.1917","article-title":"The angiotensin-converting enzyme 2\/angiotensin (1-7)\/Mas axis protects the function of pancreatic beta cells by improving the function of islet microvascular endothelial cells","volume":"34","author":"Lu","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2018.10.191_bib0320","first-page":"671","article-title":"[Effect of small interfering RNA-mediated angiotensin II type 1 receptor knockdown on first-phase insulin secretion in isolated diabetic rat islets]","volume":"35","author":"Yi","year":"2015","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0325","doi-asserted-by":"crossref","first-page":"G284","DOI":"10.1152\/ajpgi.90409.2008","article-title":"Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis","volume":"296","author":"Ulmasov","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"10","key":"10.1016\/j.biopha.2018.10.191_bib0330","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/db09-0782","article-title":"Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice","volume":"59","author":"Bindom","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2018.10.191_bib0335","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2337\/db07-0953","article-title":"Mas deficiency in FVB\/N mice produces marked changes in lipid and glycemic metabolism","volume":"57","author":"Santos","year":"2008","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.biopha.2018.10.191_bib0340","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/db16-1318","article-title":"Neprilysin is required for angiotensin-(1-7)\u2019s ability to enhance insulin secretion via its proteolytic activity to generate angiotensin-(1-2)","volume":"66","author":"Brar","year":"2017","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.191_bib0345","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.3892\/mmr.2017.6982","article-title":"Angiotensin(17) attenuates caeruleininduced pancreatic acinar cell apoptosis","volume":"16","author":"Cui","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.191_bib0350","first-page":"931","article-title":"Ang(1-7) treatment attenuates beta-cell dysfunction by improving pancreatic microcirculation in a rat model of type 2 diabetes","volume":"36","author":"Yuan","year":"2013","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.191_bib0355","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00424-010-0862-9","article-title":"Oxidative stress and beta-cell dysfunction","volume":"460","author":"Drews","year":"2010","journal-title":"Pflugers Arch."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.191_bib0360","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3892\/mmr.2016.5514","article-title":"Antioxidant effect of angiotensin (17) in the protection of pancreatic beta cell function","volume":"14","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221832821X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221832821X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:30:12Z","timestamp":1777876212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221832821X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":72,"alternative-id":["S075333221832821X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.191","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}